These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
214 related articles for article (PubMed ID: 17947390)
1. Hepatitis A vaccine versus immune globulin for postexposure prophylaxis. Victor JC; Monto AS; Surdina TY; Suleimenova SZ; Vaughan G; Nainan OV; Favorov MO; Margolis HS; Bell BP N Engl J Med; 2007 Oct; 357(17):1685-94. PubMed ID: 17947390 [TBL] [Abstract][Full Text] [Related]
2. Testing for antibody to hepatitis A to decrease the cost of hepatitis A prophylaxis with immune globulin or hepatitis A vaccines. Bryan JP; Nelson M Arch Intern Med; 1994 Mar; 154(6):663-8. PubMed ID: 8129500 [TBL] [Abstract][Full Text] [Related]
3. Post-exposure prophylaxis for hepatitis A: immune globulin, vaccine or both? Allam MF J Prev Med Hyg; 2008 Dec; 49(4):129-30. PubMed ID: 19350959 [No Abstract] [Full Text] [Related]
4. Person-to-person transmission of hepatitis A virus in an urban area of intermediate endemicity: implications for vaccination strategies. Victor JC; Surdina TY; Suleimenova SZ; Favorov MO; Bell BP; Monto AS Am J Epidemiol; 2006 Feb; 163(3):204-10. PubMed ID: 16339053 [TBL] [Abstract][Full Text] [Related]
5. Hepatitis A vaccine versus immune globulin for postexposure prophylaxis. Betz TG N Engl J Med; 2008 Jan; 358(5):531; author reply 532. PubMed ID: 18234760 [No Abstract] [Full Text] [Related]
6. Elimination of hepatitis a infection outbreaks in day care and school settings in southern Israel after introduction of the national universal toddler hepatitis a immunization program. Belmaker I; Dukhan L; Yosef Y; Leventhal A; Dagan R Pediatr Infect Dis J; 2007 Jan; 26(1):36-40. PubMed ID: 17195703 [TBL] [Abstract][Full Text] [Related]
7. Hepatitis A vaccine versus immune globulin for postexposure prophylaxis. Lee PI N Engl J Med; 2008 Jan; 358(5):531-2; author reply 532. PubMed ID: 18240428 [No Abstract] [Full Text] [Related]
8. A controlled trial of intravenous immune globulin for the prevention of serious bacterial infections in children receiving zidovudine for advanced human immunodeficiency virus infection. Pediatric AIDS Clinical Trials Group. Spector SA; Gelber RD; McGrath N; Wara D; Barzilai A; Abrams E; Bryson YJ; Dankner WM; Livingston RA; Connor EM N Engl J Med; 1994 Nov; 331(18):1181-7. PubMed ID: 7935655 [TBL] [Abstract][Full Text] [Related]
9. Feasibility of vaccination in preventing secondary cases of hepatitis A virus infection. Sagliocca L; Bianco E; Amoroso P; Quarto M; Richichi I; Tosti ME; Carannante N; Chironna M; Chiriacò P; Di Bari G; Lopalco P; Resta F; Santantonio T; Tantimonaco G; Mele A Vaccine; 2005 Jan; 23(7):910-4. PubMed ID: 15603892 [TBL] [Abstract][Full Text] [Related]
10. Immunogenicity, safety, and interchangeability of two inactivated hepatitis A vaccines in Chilean children. Abarca K; Ibánez I; Perret C; Vial P; Zinsou JA Int J Infect Dis; 2008 May; 12(3):270-7. PubMed ID: 17988917 [TBL] [Abstract][Full Text] [Related]
11. Hepatitis A vaccine versus immunoglobulin for post-exposure prophylaxis. Srivastava A; Aggarwal R Natl Med J India; 2007; 20(6):302-3. PubMed ID: 18335798 [No Abstract] [Full Text] [Related]
12. Prevention of hepatitis A infections: guidelines for use of hepatitis A vaccine and immune globulin. American Academy of Pediatrics Committee on Infectious Diseases. Pediatrics; 1996 Dec; 98(6 Pt 1):1207-15. PubMed ID: 8951284 [TBL] [Abstract][Full Text] [Related]
13. Efficacy of virosome hepatitis A vaccine in young children in Nicaragua: randomized placebo-controlled trial. Mayorga Pérez O; Herzog C; Zellmeyer M; Loáisiga A; Frösner G; Egger M J Infect Dis; 2003 Sep; 188(5):671-7. PubMed ID: 12934183 [TBL] [Abstract][Full Text] [Related]
14. Hepatitis A vaccine. Bader TF Am J Gastroenterol; 1996 Feb; 91(2):217-22. PubMed ID: 8607483 [TBL] [Abstract][Full Text] [Related]
15. [Protective efficacy of H2 strain live attenuated hepatitis A vaccines in an outbreak of hepatitis A]. Zhao Y; Meng Z; Guo J; Wang X; Duo C; Liu H; Yao J; Chai S; Zhu H; Xu Z Zhonghua Yu Fang Yi Xue Za Zhi; 2000 May; 34(3):144-6. PubMed ID: 11860920 [TBL] [Abstract][Full Text] [Related]
16. Single dose-inactivated hepatitis A vaccination schedule for susceptible youngsters. Lee SD; Chan CY; Yu MI; Wang YJ; Lo KJ; Safary A Am J Gastroenterol; 1996 Jul; 91(7):1360-2. PubMed ID: 8677995 [TBL] [Abstract][Full Text] [Related]
17. A controlled trial of a formalin-inactivated hepatitis A vaccine in healthy children. Werzberger A; Mensch B; Kuter B; Brown L; Lewis J; Sitrin R; Miller W; Shouval D; Wiens B; Calandra G N Engl J Med; 1992 Aug; 327(7):453-7. PubMed ID: 1320740 [TBL] [Abstract][Full Text] [Related]
18. [Study on the effects of controlling hepatitis A epidemics by building the colony immune defence]. Chen YZ; Jiang RJ; Yu WX; Li CH Zhonghua Liu Xing Bing Xue Za Zhi; 2003 May; 24(5):366-9. PubMed ID: 12820928 [TBL] [Abstract][Full Text] [Related]
19. Influenza vaccine immunogenicity in 6- to 23-month-old children: are identical antigens necessary for priming? Walter EB; Neuzil KM; Zhu Y; Fairchok MP; Gagliano ME; Monto AS; Englund JA Pediatrics; 2006 Sep; 118(3):e570-8. PubMed ID: 16950948 [TBL] [Abstract][Full Text] [Related]
20. Protecting contacts of hepatitis A: what's the difference between vaccine and human normal immunoglobulin? Crowcroft NS Epidemiol Infect; 2008 Jan; 136(1):10-3. PubMed ID: 17352837 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]